Pancreatic Cancer Research

ResearcherSamsung Medical CenterNo recent work listed

Hyun Jeong Jeon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5928-1375. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers

Papers 3

  1. Prognosis of pancreaticoduodenectomy in octogenarians for pancreatic ductal adenocarcinoma with propensity score matched analysis. Co-author DOI 10.1111/ans.18679↗
  2. Survival Benefit after Shifting from Upfront Surgery to Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer. Co-author DOI 10.3390/biomedicines11082302↗
  3. Pathological Response Predicts Survival after Pancreatectomy following Neoadjuvant FOLFIRINOX for Pancreatic Cancer. Co-author DOI 10.3390/cancers15010294↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. So Jeong Yoon · 3 shared papers, 2022–2023 · strength 0.55
  2. Jin Seok Heo · 3 shared papers, 2022–2023 · strength 0.55
  3. In Woong Han · 3 shared papers, 2022–2023 · strength 0.55
  4. Hongbeom Kim · 3 shared papers, 2022–2023 · strength 0.55
  5. Sang Hyun Shin · 3 shared papers, 2022–2023 · strength 0.55
  6. Hye Jeong Jeong · 3 shared papers, 2022–2023 · strength 0.55

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.